- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ALK-Abello B (0OIR)
ALK-Abello B stock price live, this page displays CSE ALKb stock exchange data. View the ALKb premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the ALK-Abello B real time stock price chart below.
What Is the ALK-Abello B Stock Price Today?
The ALK-Abello B stock price today is 149.45.
What Is the Stock Symbol for ALK-Abello B?
The stock symbol for ALK-Abello B is ""ALKb.""
What Stock Exchange Does ALK-Abello B Trade On?
ALK-Abello B is listed and trades on the Copenhagen stock exchange.
Is ALK-Abello B a Good Stock to Buy?
Determining whether ALK-Abello B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALKb quote. (ISIN: DK0061802139)
What Is the ALK-Abello B Stock Price Today?
The ALK-Abello B stock price today is 149.45.
What Is the Stock Symbol for ALK-Abello B?
The stock symbol for ALK-Abello B is ""ALKb.""
What Stock Exchange Does ALK-Abello B Trade On?
ALK-Abello B is listed and trades on the Copenhagen stock exchange.
Is ALK-Abello B a Good Stock to Buy?
Determining whether ALK-Abello B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALKb quote. (ISIN: DK0061802139)
149.45
0.00(0.00%)
Closed·
Fair Value
An estimate of a ALK-Abello B's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
149.45
215.00
52 wk Range
131.30
215.60
0OIR Scorecard
Full Analysis
Trading at a high earnings multiple
0OIR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a ALK-Abello B's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
149.45215.00
52 wk Range
131.30215.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
0OIR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a ALK-Abello B's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
ALK-Abello B Company Profile
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mites, grass and tree pollen, ragweed, Japanese cedar, and food. It also provides consumer healthcare solution, which include Digital eco-system, a platform which connect and engages with allergy sufferers in the disease journey through tools and e-commerce offerings that provide support, guidance, and relief, as well as smoothing the path to allergy immunotherapy treatment. In addition, the company offers diagnostic allergy solutions through testing by skin prick test or blood test; and emergency treatment, such as intra-muscular injection of adrenaline for the treatment of acute life-threatening allergic reactions, including anaphylaxis. It has a collaboration with Torii Pharmaceutical Co., Ltd. for the development of GRAZAX, a grass pollen allergy tablet; CEDARCURE, a tablet for the treatment of Japanese cedar pollen induced allergy; and MITICURE for the treatment of house dust mite-induced allergy. ALK-Abelló A/S was founded in 1923 and is headquartered in Horsholm, Denmark.
Compare 0OIR to Peers and Sector
Metrics to compare | 0OIR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship0OIRPeersSector | |
|---|---|---|---|---|
P/E Ratio | 47.2x | 14.1x | −0.7x | |
PEG Ratio | 0.84 | 0.16 | 0.00 | |
Price/Book | 8.1x | 2.5x | 2.6x | |
Price / LTM Sales | 8.1x | 3.6x | 3.4x | |
Upside (Analyst Target) | - | 22.8% | 35.7% | |
Fair Value Upside | Unlock | 9.4% | 4.1% | Unlock |
Earnings
Latest Release
Aug 21, 2025
EPS / Forecast
1.20 / --
Revenue / Forecast
1.53B / --
People Also Watch
FAQ
What Stock Exchange Does ALK-Abello B Trade On?
ALK-Abello B is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for ALK-Abello B?
The stock symbol for ALK-Abello B is "0OIR."
What Is the ALK-Abello B Market Cap?
As of today, ALK-Abello B market cap is 47.16B.
What Is ALK-Abello B's Earnings Per Share (TTM)?
The ALK-Abello B EPS (TTM) is 4.47.
From a Technical Analysis Perspective, Is 0OIR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has ALK-Abello B Stock Split?
ALK-Abello B has split 1 times.
How Many Employees Does ALK-Abello B Have?
ALK-Abello B has 2782 employees.
What is the current trading status of ALK-Abello B (0OIR)?
As of 09 Oct 2025, ALK-Abello B (0OIR) is trading at a price of 149.45, with a previous close of 149.45. The stock has fluctuated within a day range of 212.40 to 215.00, while its 52-week range spans from 131.30 to 215.60.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.